
Eglucent Rapid (3ml Each) Solution for Injection
Marketer
Lupin Ltd
Salt Composition
Insulin Lispro (100IU/ml)
Overview Eglucent Rapid (3ml Each) Solution for Injection
Fast-acting insulin, InsuRapid (3ml vials), effectively manages blood glucose in individuals with type 1 and type 2 diabetes. Administered via subcutaneous injection, it rapidly lowers post-prandial glucose, mitigating the risk of severe diabetic complications. InsuRapid is typically prescribed alongside a longer-acting insulin or other antidiabetic agents. Proper injection technique will be demonstrated by your healthcare provider. Inject 15 minutes before or within 20 minutes of a meal. Discontinue only under medical supervision. This medication is part of a comprehensive diabetes management plan, incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Consistent blood glucose monitoring, recording, and sharing of results with your physician is crucial for optimal dose adjustment. Hypoglycemia is the most frequent adverse effect. Precise dosing, regular glucose monitoring, and consistent mealtimes minimize this risk. Excessive alcohol consumption can also trigger hypoglycemia. Additional side effects may include injection site reactions (redness, swelling, lipodystrophy). Weight gain is also a possibility. Avoid use with pre-existing hypoglycemia. Prior to commencing treatment, disclose any history of kidney, liver, or heart disease. Pregnant or lactating individuals should consult their physician regarding dosage adjustments.
Uses of Eglucent Rapid (3ml Each) Solution for Injection
Managing Diabetes Mellitus
Major Benefits of Eglucent Rapid (3ml Each) Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Eglucent Rapid (3ml Each) Solution for Injection:
- Hypoglycemia (low blood glucose level)
How to use Eglucent Rapid (3ml Each) Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Eglucent Rapid (3ml Each) Solution for Injection works:
InstaGlice, a rapid-acting injectable solution (3ml per dose), initiates its effect within 10 to 20 minutes post-injection. Functionally mirroring endogenous insulin, it promotes glucose absorption by muscle and adipose tissue while simultaneously inhibiting hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Eglucent Rapid (3ml Each) Injectable Solution is contraindicated.
PregnancySAFE IF PRESCRIBED
Injection-ready Eglucent Rapid (3ml per vial) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or absent harm to offspring; yet, data from human trials remains scarce.
Breast feedingSAFE IF PRESCRIBED
Eglucent Rapid injectable solution (3ml per vial) poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, signifying negligible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Injectable Eglucent Rapid (3ml units) requires careful administration in individuals with impaired kidney function. Dosage modification of injectable Eglucent Rapid (3ml units) may be necessary. Physician consultation is recommended. Regular blood glucose level monitoring is crucial for appropriate dosage management.
LiverCAUTION
Patients with hepatic impairment should use Eglucent Rapid (3ml per vial) injectable solution cautiously, potentially requiring dose modification. Blood glucose levels should be closely and consistently monitored to guide appropriate dosage adjustments. Physician consultation is recommended.
What if you forget to take Eglucent Rapid (3ml Each) Solution for Injection :
Delayed administration of Eglucent Rapid (3ml single-dose vials) injection may lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust subsequent dosing as needed.
Facts to Know About Eglucent Rapid (3ml Each) Solution for Injection
| Label | Value |
|---|---|
| Chemical Category | Modified insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Actions | Fast-acting insulin analogs |
